PMS2 and uterine cancer: The bar graph in Figure 10 illustrates the absolute risk of uterine cancer among the general population (3.1%), women with a family history of uterine cancer (4.34%), women with Lynch Syndrome with MMR gene mutations (82.7–110%), and women with Lynch syndrome with PMS2 mutations (17.7%) Absolute risk was calculated by estimating the product between the absolute risk of the general population and the reported odds ratio/cumulative incidences/relative risk of the reported studies.